Apimeds Pharmaceuticals US, Inc.: Other Events (APUS)

Oct 13, 2026, 9:15 AM ETDealRead the original at SEC EDGAR

Good for APUS

Apimeds' subsidiary signed a two-year deal to build and run an insurance-record system. The fixed development payments add paid work, though service fees are unsettled and the token payment depends on a token being created and having value.

APUS · Apimeds Pharmaceuticals US, Inc.

AI read · Good for APUS

The AI's read

This gives MindWave a defined project and quarterly development payments, creating a new source of business for Apimeds. The size of those payments is not stated. Ongoing service fees still need agreement, and the token payment depends on BlockAssure creating the token and it having value.

Get alerts for APUS

Follow Apimeds Pharmaceuticals US, Inc. (APUS) free. When we publish a story about it, you get the plain-English explanation as an alert.

Get alerts for APUS

Free on the App Store and Google Play, or on the web.